XENE: Xenon Pharmaceuticals Inc.
Performance
XENE +5.75%
Watchlist
Select an item
Summary
XENE at a glance
XENE returned +5.75% over the past year and +2.70% a year over five years. Its worst drop in that year was -52.80%, smaller than 19% of stocks on Redstone, and its Sharpe ratio of 0.34 beats 43% of stocks on Redstone. It pays no dividends.
Current Drawdown
-43.00%
Rolling Volatility
40.03%
Actions
Metrics
Risk Indicators
Alpha15.45%
Beta0.79x
Sharpe0.34
Sortino0.60
Omega1.10
Calmar0.11
Martin1.13
Profile
About XENE
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $3.9B
- Listed
- Nov 2014
- Employees
- 370
- Headquarters
- Burnaby
- Website
- xenon-pharma.com
Comparisons